Stephen Kanes
CIK 1612859 · Chief Medical Officer · last filed 2026-02-03
Stephen Kanes is a Chief Medical Officer who has filed 27 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for CNTA, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$14.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.77M
2
27
-$14.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTA | Chief Medical Officer | 120,000 | $39.72 | $4.77M | $0 | 2 | 2026-02-03 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Chief Medical Officer | 14,591 | $8.68 | $126.6K | -$14.44M | 25 | 2021-10-21 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | CNTA | Grant (A) | +120,000 | $0 | EDGAR |
| 2025-02-04 | CNTA | Grant (A) | — | $0 | EDGAR |
| 2021-10-21 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +2,680 | -$45.1K | EDGAR |
| 2021-06-17 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +2,499 | -$58.9K | EDGAR |
| 2021-02-12 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-30 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-05 | Sage Therapeutics, Inc. (SAGE) Delisted | Exer (M) | +6,000 | $2.7K | EDGAR |
| 2019-07-29 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +1,351 | -$88.6K | EDGAR |
| 2019-06-25 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |